Umehara H - Search Results

1

Miz1 represses type I interferon production and limits viral clearance during influenza A virus infection.

Wu W, Arunagiri V, Do-Umehara HC, Chen C, Gu S, Biswas I, Ridge KM, Budinger GRS, Liu S, Liu J. Wu W, et al. Among authors: do umehara hc. Sci Signal. 2024 Apr 9;17(831):eadg7867. doi: 10.1126/scisignal.adg7867. Epub 2024 Apr 9. Sci Signal. 2024. PMID: 38593156

2

Utility of intraoral scanner imaging for dental plaque detection.

Yoshiga C, Doi K, Oue H, Kobatake R, Kawagoe M, Umehara H, Tsuga K. Yoshiga C, et al. Among authors: umehara h. Imaging Sci Dent. 2024 Mar;54(1):43-48. doi: 10.5624/isd.20230180. Epub 2024 Jan 4. Imaging Sci Dent. 2024. PMID: 38571782 Free PMC article.

3

Expression of USP25 associates with fibrosis, inflammation and metabolism changes in IgG4-related disease.

Jiang P, Jing Y, Zhao S, Lan C, Yang L, Dai X, Luo L, Cai S, Zhu Y, Miller H, Lai J, Zhang X, Zhao X, Wu Y, Yang J, Zhang W, Guan F, Zhong B, Umehara H, Lei J, Dong L, Liu C. Jiang P, et al. Among authors: umehara h. Nat Commun. 2024 Mar 23;15(1):2627. doi: 10.1038/s41467-024-45977-7. Nat Commun. 2024. PMID: 38521787 Free PMC article.

4

Comparison of plaque control record measurements obtained using intraoral scanner and direct visualization.

Doi K, Yoshiga C, Oue H, Kobatake R, Kawagoe M, Umehara H, Wakamatsu K, Tsuga K. Doi K, et al. Among authors: umehara h. Clin Exp Dent Res. 2024 Feb;10(1):e852. doi: 10.1002/cre2.852. Clin Exp Dent Res. 2024. PMID: 38345487 Free PMC article.

5

Associations between negative and positive automatic thoughts and clinical variables in patients with schizophrenia.

Takeda T, Nakataki M, Umehara H, Numata S. Takeda T, et al. Among authors: umehara h. Schizophr Res Cogn. 2023 Dec 2;35:100298. doi: 10.1016/j.scog.2023.100298. eCollection 2024 Mar. Schizophr Res Cogn. 2023. PMID: 38115993 Free PMC article.

6

Effects of group therapy on jumping to conclusion bias in adolescents with autism spectrum disorder : An exploratory study.

Umehara H, Takeda T, Yoshida L, Matsuura K, Okumura-Fujita M, Tominaga R, Abe Y, Masuda T, Yamada N, Numata S. Umehara H, et al. J Med Invest. 2023;70(1.2):115-122. doi: 10.2152/jmi.70.115. J Med Invest. 2023. PMID: 37164706 Free article.

7

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.

Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.

8

DSP-0509, a systemically available TLR7 agonist, exhibits combination effect with immune checkpoint blockade by activating anti-tumor immune effects.

Ota Y, Nagai Y, Hirose Y, Hori S, Koga-Yamakawa E, Eguchi K, Sumida K, Murata M, Umehara H, Yamamoto S. Ota Y, et al. Among authors: umehara h. Front Immunol. 2023 Jan 30;14:1055671. doi: 10.3389/fimmu.2023.1055671. eCollection 2023. Front Immunol. 2023. PMID: 36793737 Free PMC article.

9

Long-term safety and efficacy of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to methotrexate.

Tanaka Y, Takeuchi T, Yamanaka H, Nanki T, Umehara H, Yasuda N, Tago F, Kitahara Y, Kawakubo M, Torii K, Hojo S, Kawano T, Imai T. Tanaka Y, et al. Among authors: umehara h. Mod Rheumatol. 2023 Dec 22;34(1):37-44. doi: 10.1093/mr/road004. Mod Rheumatol. 2023. PMID: 36680426 Clinical Trial.

10

Long-term evaluation of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs.

Tanaka Y, Takeuchi T, Yamanaka H, Nanki T, Umehara H, Yasuda N, Tago F, Kitahara Y, Kawakubo M, Torii K, Hojo S, Kawano T, Imai T. Tanaka Y, et al. Among authors: umehara h. Mod Rheumatol. 2023 Dec 22;34(1):45-49. doi: 10.1093/mr/road005. Mod Rheumatol. 2023. PMID: 36680420 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

285 results

Search Page